188 related articles for article (PubMed ID: 2316495)
21. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
22. Diabetic neuropathy in Mauritius: prevalence and risk factors.
Shaw JE; Hodge AM; de Courten M; Dowse GK; Gareeboo H; Tuomilehto J; Alberti KG; Zimmet PZ
Diabetes Res Clin Pract; 1998 Nov; 42(2):131-9. PubMed ID: 9886750
[TBL] [Abstract][Full Text] [Related]
23. Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.
Ponirakis G; Abdul-Ghani MA; Jayyousi A; Zirie MA; Qazi M; Almuhannadi H; Petropoulos IN; Khan A; Gad H; Migahid O; Megahed A; Al-Mohannadi S; AlMarri F; Al-Khayat F; Mahfoud Z; Al Hamad H; Ramadan M; DeFronzo R; Malik RA
J Diabetes Investig; 2021 Sep; 12(9):1642-1650. PubMed ID: 33714226
[TBL] [Abstract][Full Text] [Related]
24. Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings.
Qureshi MS; Iqbal M; Zahoor S; Ali J; Javed MU
J Endocrinol Invest; 2017 Apr; 40(4):425-430. PubMed ID: 27848229
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance.
Laitinen T; Lindström J; Eriksson J; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M
Diabet Med; 2011 Jun; 28(6):699-704. PubMed ID: 21388444
[TBL] [Abstract][Full Text] [Related]
26. A questionnaire for neurological symptoms in patients with diabetes--cross-sectional multicenter study in Saitama Prefecture, Japan.
Kawano M; Omori Y; Katayama S; Kawakami M; Suzuki Y; Takahashi K; Takemura Y; Nagata N; Hiratsuka A; Matsuzaki F; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 2001 Oct; 54(1):41-7. PubMed ID: 11532329
[TBL] [Abstract][Full Text] [Related]
27. Symptoms and complications of adult diabetic patients in a family practice.
Konen JC; Curtis LG; Summerson JH
Arch Fam Med; 1996 Mar; 5(3):135-45. PubMed ID: 8620254
[TBL] [Abstract][Full Text] [Related]
28. Hypertension among rural Hispanics and non-Hispanic whites: the San Luis Valley Diabetes Study.
Rewers M; Shetterly SM; Hamman RF
Public Health Rep; 1996; 111 Suppl 2(Suppl 2):27-9. PubMed ID: 8898767
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Sensory Neuropathy in Type 2 Diabetes Mellitus and Its Correlation with Duration of Disease.
Karki DB; Yadava SK; Pant S; Thusa N; Dangol E; Ghimire S
Kathmandu Univ Med J (KUMJ); 2016; 14(54):120-124. PubMed ID: 28166066
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
Adams OP; Herbert JR; Howitt C; Unwin N
Diabet Med; 2019 Dec; 36(12):1629-1636. PubMed ID: 31094005
[TBL] [Abstract][Full Text] [Related]
31. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study.
Marshall JA; Hoag S; Shetterly S; Hamman RF
Diabetes Care; 1994 Jan; 17(1):50-6. PubMed ID: 8112189
[TBL] [Abstract][Full Text] [Related]
32. Subclinical diabetic neuropathy: a common complication in Saudi diabetics.
Akbar DH; Mira SA; Zawawi TH; Malibary HM
Saudi Med J; 2000 May; 21(5):433-7. PubMed ID: 11500676
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study.
Maser RE; Steenkiste AR; Dorman JS; Nielsen VK; Bass EB; Manjoo Q; Drash AL; Becker DJ; Kuller LH; Greene DA
Diabetes; 1989 Nov; 38(11):1456-61. PubMed ID: 2620781
[TBL] [Abstract][Full Text] [Related]
34. Excess incidence of known non-insulin-dependent diabetes mellitus (NIDDM) in Hispanics compared with non-Hispanic whites in the San Luis Valley, Colorado.
Baxter J; Hamman RF; Lopez TK; Marshall JA; Hoag S; Swenson CJ
Ethn Dis; 1993; 3(1):11-21. PubMed ID: 8508101
[TBL] [Abstract][Full Text] [Related]
35. [Value of the determination of vibration sensitivity in diabetics (type I and II)].
Kroetlinger M
Wien Med Wochenschr; 1983 Nov; 133(21):539-42. PubMed ID: 6659520
[TBL] [Abstract][Full Text] [Related]
36. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).
Azad N; Emanuele NV; Abraira C; Henderson WG; Colwell J; Levin SR; Nuttall FQ; Comstock JP; Sawin CT; Silbert C; Rubino FA
J Diabetes Complications; 1999; 13(5-6):307-13. PubMed ID: 10765007
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China.
Li L; Chen J; Wang J; Cai D
Prim Care Diabetes; 2015 Jun; 9(3):191-5. PubMed ID: 25163987
[TBL] [Abstract][Full Text] [Related]
39. Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Ueda T; Senba H; Todo Y; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
Neurourol Urodyn; 2016 Nov; 35(8):1024-1027. PubMed ID: 26352009
[TBL] [Abstract][Full Text] [Related]
40. The role of dietary fiber in the etiology of non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study.
Marshall JA; Weiss NS; Hamman RF
Ann Epidemiol; 1993 Jan; 3(1):18-26. PubMed ID: 8287151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
